Genomic and Epigenomic Characterization of Tumor Organoid Models.

biomarker epigenomics genomics organoid patient-derived organoid pharmacogenomics

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
24 Aug 2022
Historique:
received: 03 08 2022
revised: 20 08 2022
accepted: 22 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 10 9 2022
Statut: epublish

Résumé

Tumor organoid modeling has been recognized as a state-of-the-art system for in vitro research on cancer biology and precision oncology. Organoid culture technologies offer distinctive advantages, including faithful maintenance of physiological and pathological characteristics of human disease, self-organization into three-dimensional multicellular structures, and preservation of genomic and epigenomic landscapes of the originating tumor. These features effectively position organoid modeling between traditional cell line cultures in two dimensions and in vivo animal models as a valid, versatile, and robust system for cancer research. Here, we review recent advances in genomic and epigenomic characterization of tumor organoids and the novel findings obtained, highlight significant progressions achieved in organoid modeling of gene-drug interactions and genotype-phenotype associations, and offer perspectives on future opportunities for organoid modeling in basic and clinical cancer research.

Identifiants

pubmed: 36077628
pii: cancers14174090
doi: 10.3390/cancers14174090
pmc: PMC9454968
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R37 CA237022
Pays : United States
Organisme : NCI NIH HHS
ID : P30CA014089
Pays : United States
Organisme : NIH HHS
ID : R37CA237022
Pays : United States

Références

Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33628-33638
pubmed: 33318192
Nat Genet. 2021 Jun;53(6):881-894
pubmed: 33972779
Nature. 2012 Apr 29;485(7397):195-200
pubmed: 22575959
J Exp Med. 2017 Mar 6;214(3):579-596
pubmed: 28232471
Nat Commun. 2019 Dec 5;10(1):5549
pubmed: 31804471
Neuron. 2017 May 3;94(3):550-568.e10
pubmed: 28472656
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
Cell Rep. 2020 May 12;31(6):107625
pubmed: 32402285
Cell. 2018 Aug 9;174(4):856-869.e17
pubmed: 30096312
Cell. 2014 Sep 25;159(1):176-187
pubmed: 25201530
Nature. 2012 Aug 30;488(7413):665-9
pubmed: 22895187
Int J Oncol. 2016 Jul;49(1):402-10
pubmed: 27120977
Cell. 2018 Apr 5;173(2):515-528.e17
pubmed: 29625057
Cancer Discov. 2019 Feb;9(2):282-301
pubmed: 30366930
Cancer Discov. 2021 Feb;11(2):362-383
pubmed: 33158842
Mol Oncol. 2011 Aug;5(4):387-93
pubmed: 21821475
Nature. 2014 Oct 16;514(7522):385-8
pubmed: 25252974
Nat Commun. 2020 Mar 11;11(1):1310
pubmed: 32161258
Stem Cells Transl Med. 2022 Apr 29;11(4):415-433
pubmed: 35325233
Cancer Cell. 2011 Aug 16;20(2):260-75
pubmed: 21840489
Cell Stem Cell. 2016 Jun 2;18(6):686-687
pubmed: 27257754
Cell. 2007 Oct 19;131(2):378-90
pubmed: 17956737
Nature. 2016 Mar 3;531(7592):47-52
pubmed: 26909576
Cancer Discov. 2019 Jul;9(7):852-871
pubmed: 31053628
Nature. 2014 Sep 11;513(7517):202-9
pubmed: 25079317
Nat Genet. 2020 Feb;52(2):219-230
pubmed: 32025000
Br J Cancer. 2013 Jul 23;109(2):512-25
pubmed: 23756868
Cancer Cell. 2004 Jun;5(6):539-51
pubmed: 15193257
Cancer Cell. 2019 Feb 11;35(2):315-328.e6
pubmed: 30753828
Cell. 2015 May 7;161(4):933-45
pubmed: 25957691
Clin Cancer Res. 2004 Jul 15;10(14):4661-9
pubmed: 15269138
Neoplasia. 2018 Mar;20(3):263-279
pubmed: 29462756
Cell. 2018 Sep 6;174(6):1586-1598.e12
pubmed: 30100188
Science. 2017 Oct 13;358(6360):234-238
pubmed: 28912133
Cancer Discov. 2018 Nov;8(11):1404-1421
pubmed: 30213835
Mol Pharmacol. 2004 Jul;66(1):25-32
pubmed: 15213293
Cell Stem Cell. 2018 Mar 1;22(3):454-467.e6
pubmed: 29337182
Nature. 2015 May 7;521(7550):43-7
pubmed: 25924068
Cancer Discov. 2018 Sep;8(9):1112-1129
pubmed: 29853643
Nat Commun. 2019 Oct 8;10(1):4571
pubmed: 31594944
Cell. 2018 Jan 11;172(1-2):373-386.e10
pubmed: 29224780
Cancer Res. 2007 Mar 15;67(6):2701-11
pubmed: 17363591
Cell Rep. 2020 Jun 16;31(11):107762
pubmed: 32553164
Nat Commun. 2022 Apr 21;13(1):2169
pubmed: 35449156
Cancer Discov. 2021 Jun;11(6):1562-1581
pubmed: 33451982
Cell Host Microbe. 2015 Jun 10;17(6):763-74
pubmed: 26028364
EBioMedicine. 2015 Jul 08;2(7):660-70
pubmed: 26288838
Nat Rev Cancer. 2016 Feb;16(2):110-20
pubmed: 26775620
Nat Genet. 2014 Jun;46(6):573-82
pubmed: 24816253
Nature. 2018 Apr;556(7702):457-462
pubmed: 29643510
Gastroenterology. 2015 Jan;148(1):126-136.e6
pubmed: 25307862
Cancer Cell. 2015 Apr 13;27(4):516-32
pubmed: 25873174
Cell Stem Cell. 2016 Jun 2;18(6):827-838
pubmed: 27212702

Auteurs

Chehyun Nam (C)

Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.

Benjamin Ziman (B)

Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.

Megha Sheth (M)

Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.

Hua Zhao (H)

Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.

De-Chen Lin (DC)

Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA.

Classifications MeSH